Budget Impact of an Individualized Approach in the Treatment of HBeAg-Negative CHB Patients Exploiting the Week-12 Peginterferon Alfa-2a Stopping Rule in Italy
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.132
https://www.valueinhealthjournal.com/article/S1098-3015(13)02037-8/fulltext
Title :
Budget Impact of an Individualized Approach in the Treatment of HBeAg-Negative CHB Patients Exploiting the Week-12 Peginterferon Alfa-2a Stopping Rule in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02037-8&doi=10.1016/j.jval.2013.08.132
First page :
A344
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
119